A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

Eli Lilly (NYSE: LLY) led the way in pharma M&A during June. The US pharma major announced two major deals in the month, both ...

Brazil scrambled to craft a measured but strong response to US President Donald Trump’s surprise tariff hike on Thursday in ...

PLC, based on Brackla Industrial Estate in Bridgend, has secured three new patents in the United States and Europe. It has ...

US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...

T.I. has hit a legal roadblock in New York, where a federal judge issued an injunction preventing him and Grand Hustle Films from using the title “Situationships” for their upcoming […] The post ...

Recently, the United States has witnessed an intense legal and commercial confrontation between major pharmaceutical ...

By attacking Brazil’s sovereignty, Trump may have handed the leftist president a political and diplomatic opportunity.

The US court also barred the Viljoens from using the Tammy Taylor name and logos as well as the products in their nail salons ...

Continuing last week’s letter from Alec to Mabel, legal matters had progressed exceedingly well with the telephone patent suit against Western Union. As Alec wrote, their lawyer had opted to base the ...

Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.